When Evil Lurks (2023)
| Theatrical Performance | ||
| Domestic Box Office | $546,626 | Details |
| International Box Office | $1,147,958 | |
| Worldwide Box Office | $1,694,584 | |
| Domestic Physical Disc Sales | ||
| Blu-ray Sales (estimated) | $149,718 | |
| Total | $149,718 | |
| Further financial details... | ||
Synopsis
When brothers Pedro and Jimmy discover that a demonic infection has been festering in a nearby farmhouse—its very proximity poisoning the local livestock—they attempt to evict the victim from their land. Failing to adhere to the proper rites of exorcism, their reckless actions inadvertently trigger an epidemic of possessions across their rural community. Now they must outrun an encroaching evil as it corrupts and mutilates everyone it is exposed to, and enlist the aid of a wizened “cleaner,” who holds the only tools that can stop this supernatural plague.
Metrics
| Opening Weekend: | $205,752 (37.6% of total gross) |
| Legs: | 2.66 (domestic box office/biggest weekend) |
| Domestic Share: | 32.3% (domestic box office/worldwide) |
| Theater counts: | 659 opening theaters/659 max. theaters, 1.7 weeks average run per theater |
| Infl. Adj. Dom. BO | $597,593 |
Movie Details
| Domestic Releases: | October 6th, 2023 (Wide) by IFC Films |
| International Releases: | November 9th, 2023 (Limited), released as When Evil Lurks (ОДЕРЖИМЫЕ ЗЛОМ) (Russia (CIS))
January 11th, 2024 (Wide), released as Cuando Acecha la Maldad (Uruguay) January 11th, 2024 (Limited), released as Cuando Acecha La Maldad (Mexico) January 11th, 2024 (Limited), released as Quando o Mal Espreita (Portugal) January 19th, 2024 (Limited), released as Cuando Acecha La Maldad (Spain) |
| Video Release: | October 27th, 2023 by Shudder |
| Running Time: | 100 minutes |
| Film festival: | Toronto International Film Festival 2023 |
| Social setting: | Epidemic |
| Subgenre: | Supernatural Horror |
| Source: | Original Screenplay |
| Genre: | Horror |
| Production Method: | Live Action |
| Creative Type: | Contemporary Fiction |
| Production Countries: | Argentina, United States |
| Languages: | Spanish |
Weekend Box Office Performance
| Date | Rank | Gross | % Change | Theaters | Per Theater | Total Gross | Week |
|---|---|---|---|---|---|---|---|
| Oct 6, 2023 | - | $205,752 | 659 | $312 | $205,752 | 1 | |
| Oct 13, 2023 | - | $61,213 | -70% | 330 | $185 | $425,155 | 2 |
| Oct 20, 2023 | - | $23,112 | -62% | 82 | $282 | $527,018 | 3 |
| Oct 27, 2023 | - | $2,428 | -89% | 22 | $110 | $544,725 | 4 |
Daily Box Office Performance
| Date | Rank | Gross | %YD | %LW | Theaters | Per Theater | Total Gross | Days |
|---|---|---|---|---|---|---|---|---|
| Oct 6, 2023 | - | $69,172 | 659 | $105 | $69,172 | 1 | ||
| Oct 7, 2023 | - | $76,608 | +11% | 659 | $116 | $145,780 | 2 | |
| Oct 8, 2023 | - | $59,972 | -22% | 659 | $91 | $205,752 | 3 | |
| Oct 9, 2023 | - | $39,705 | -34% | 659 | $60 | $245,457 | 4 | |
| Oct 10, 2023 | - | $41,357 | +4% | 659 | $63 | $286,814 | 5 | |
| Oct 11, 2023 | - | $37,285 | -10% | 659 | $57 | $324,099 | 6 | |
| Oct 12, 2023 | - | $39,843 | +7% | 659 | $60 | $363,942 | 7 | |
| Oct 13, 2023 | - | $23,630 | -41% | -66% | 659 | $36 | $387,572 | 8 |
| Oct 14, 2023 | - | $22,563 | -5% | -71% | 330 | $68 | $410,135 | 9 |
| Oct 15, 2023 | - | $15,020 | -33% | -75% | 330 | $46 | $425,155 | 10 |
| Oct 16, 2023 | - | $24,014 | +60% | -40% | 330 | $73 | $449,169 | 11 |
| Oct 17, 2023 | - | $28,005 | +17% | -32% | 330 | $85 | $477,174 | 12 |
| Oct 18, 2023 | - | $22,410 | -20% | -40% | 330 | $68 | $499,584 | 13 |
| Oct 19, 2023 | - | $4,322 | -81% | -89% | 330 | $13 | $503,906 | 14 |
Weekly Box Office Performance
| Date | Rank | Gross | % Change | Theaters | Per Theater | Total Gross | Week |
|---|---|---|---|---|---|---|---|
| Oct 6, 2023 | 21 | $363,942 | 659 | $552 | $363,942 | 1 | |
| Oct 13, 2023 | 25 | $139,964 | -62% | 330 | $424 | $503,906 | 2 |
| Oct 20, 2023 | 32 | $38,391 | -73% | 82 | $468 | $542,297 | 3 |
| Oct 27, 2023 | 45 | $4,329 | -89% | 22 | $197 | $546,626 | 4 |
Full financial estimates for this film, including domestic and international box office, video sales, video rentals, TV and ancillary revenue are available through our research services. For more information, please contact us at research@the-numbers.com.
Synopsis
When brothers Pedro and Jimmy discover that a demonic infection has been festering in a nearby farmhouse—its very proximity poisoning the local livestock—they attempt to evict the victim from their land. Failing to adhere to the proper rites of exorcism, their reckless actions inadvertently trigger an epidemic of possessions across their rural community. Now they must outrun an encroaching evil as it corrupts and mutilates everyone it is exposed to, and enlist the aid of a wizened “cleaner,” who holds the only tools that can stop this supernatural plague.
Metrics
| Opening Weekend: | $205,752 (37.6% of total gross) |
| Legs: | 2.66 (domestic box office/biggest weekend) |
| Domestic Share: | 32.3% (domestic box office/worldwide) |
| Theater counts: | 659 opening theaters/659 max. theaters, 1.7 weeks average run per theater |
| Infl. Adj. Dom. BO | $597,593 |
Movie Details
| Domestic Releases: | October 6th, 2023 (Wide) by IFC Films |
| International Releases: | November 9th, 2023 (Limited), released as When Evil Lurks (ОДЕРЖИМЫЕ ЗЛОМ) (Russia (CIS))
January 11th, 2024 (Wide), released as Cuando Acecha la Maldad (Uruguay) January 11th, 2024 (Limited), released as Cuando Acecha La Maldad (Mexico) January 11th, 2024 (Limited), released as Quando o Mal Espreita (Portugal) January 19th, 2024 (Limited), released as Cuando Acecha La Maldad (Spain) |
| Video Release: | October 27th, 2023 by Shudder |
| Running Time: | 100 minutes |
| Film festival: | Toronto International Film Festival 2023 |
| Social setting: | Epidemic |
| Subgenre: | Supernatural Horror |
| Source: | Original Screenplay |
| Genre: | Horror |
| Production Method: | Live Action |
| Creative Type: | Contemporary Fiction |
| Production Countries: | Argentina, United States |
| Languages: | Spanish |
Weekend Box Office Performance
| Date | Rank | Gross | % Change | Theaters | Per Theater | Total Gross | Week |
|---|---|---|---|---|---|---|---|
| Oct 6, 2023 | - | $205,752 | 659 | $312 | $205,752 | 1 | |
| Oct 13, 2023 | - | $61,213 | -70% | 330 | $185 | $425,155 | 2 |
| Oct 20, 2023 | - | $23,112 | -62% | 82 | $282 | $527,018 | 3 |
| Oct 27, 2023 | - | $2,428 | -89% | 22 | $110 | $544,725 | 4 |
Daily Box Office Performance
| Date | Rank | Gross | %YD | %LW | Theaters | Per Theater | Total Gross | Days |
|---|---|---|---|---|---|---|---|---|
| Oct 6, 2023 | - | $69,172 | 659 | $105 | $69,172 | 1 | ||
| Oct 7, 2023 | - | $76,608 | +11% | 659 | $116 | $145,780 | 2 | |
| Oct 8, 2023 | - | $59,972 | -22% | 659 | $91 | $205,752 | 3 | |
| Oct 9, 2023 | - | $39,705 | -34% | 659 | $60 | $245,457 | 4 | |
| Oct 10, 2023 | - | $41,357 | +4% | 659 | $63 | $286,814 | 5 | |
| Oct 11, 2023 | - | $37,285 | -10% | 659 | $57 | $324,099 | 6 | |
| Oct 12, 2023 | - | $39,843 | +7% | 659 | $60 | $363,942 | 7 | |
| Oct 13, 2023 | - | $23,630 | -41% | -66% | 659 | $36 | $387,572 | 8 |
| Oct 14, 2023 | - | $22,563 | -5% | -71% | 330 | $68 | $410,135 | 9 |
| Oct 15, 2023 | - | $15,020 | -33% | -75% | 330 | $46 | $425,155 | 10 |
| Oct 16, 2023 | - | $24,014 | +60% | -40% | 330 | $73 | $449,169 | 11 |
| Oct 17, 2023 | - | $28,005 | +17% | -32% | 330 | $85 | $477,174 | 12 |
| Oct 18, 2023 | - | $22,410 | -20% | -40% | 330 | $68 | $499,584 | 13 |
| Oct 19, 2023 | - | $4,322 | -81% | -89% | 330 | $13 | $503,906 | 14 |
Weekly Box Office Performance
| Date | Rank | Gross | % Change | Theaters | Per Theater | Total Gross | Week |
|---|---|---|---|---|---|---|---|
| Oct 6, 2023 | 21 | $363,942 | 659 | $552 | $363,942 | 1 | |
| Oct 13, 2023 | 25 | $139,964 | -62% | 330 | $424 | $503,906 | 2 |
| Oct 20, 2023 | 32 | $38,391 | -73% | 82 | $468 | $542,297 | 3 |
| Oct 27, 2023 | 45 | $4,329 | -89% | 22 | $197 | $546,626 | 4 |
Full financial estimates for this film, including domestic and international box office, video sales, video rentals, TV and ancillary revenue are available through our research services. For more information, please contact us at research@the-numbers.com.